Healthcare Finance — Asset

The decision facing most borrowers is not whether healthcare finance — asset exists but whether it is the cheapest way to hold risk for the period involved. Clinical equipment is only worth its residual value while it is supported and calibrated, so funders underwrite the maintenance contract as closely as the machine.

Structurally, the facility is secured on the asset itself, held under a hire purchase or lease agreement, written over terms of two to seven years, matched to the useful economic life of the asset, with funding of up to 100% of the equipment cost where a manufacturer maintenance contract is in place, with a deposit required on used or uncontracted clinical equipment. Lenders assess the exit before the entry: the agreement amortises to title transfer or a technology-refresh upgrade, with residual values dependent on remaining service life and calibration records. That ordering explains why two applicants with identical income can receive materially different terms — the credit question is whether the repayment route survives a slower market, not whether the borrower looks creditworthy today.

Activity in this segment comes from bank healthcare desks funding practice equipment, medical and dental equipment finance specialists and manufacturer and vendor finance arms. Each prices the same healthcare finance case against its own funding cost and risk appetite, which is why the same healthcare finance — asset case can attract offers several percentage points apart. The Financial Conduct Authority supervision shapes conduct standards and, where the borrowing is regulated, the advice and disclosure obligations that sit around the transaction.

The nearest alternatives are a managed-service contract where the supplier retains ownership, including the equipment within a healthcare property facility and a practice loan where the requirement is broader than equipment. Each solves a slightly different problem: some are cheaper but slower, others are faster but priced for short exposure, and a few avoid taking a charge over the asset altogether. The right comparison is total cost over the period the money is actually needed.

Where the requirement is short and the exit is certain, a short-dated facility usually wins on total cost even at a higher rate, because the interest is charged for months rather than years. Where the asset is held for the long term and the income is stable, the opposite is true and a term facility priced on a flat or annual percentage rate applied to the asset value, plus a documentation fee is the cheaper way to hold the position. Clinical equipment is only worth its residual value while it is supported and calibrated, so funders underwrite the maintenance contract as closely as the machine.

A broker or adviser adds most value at this point rather than at application. Comparing medical and dental equipment finance specialists, manufacturer and vendor finance arms and bank healthcare desks funding practice equipment on a like-for-like basis, including fees and exit terms, is the step that determines the cost of the transaction — the paperwork that follows is largely administrative.

Healthcare finance — asset is most commonly used where surgery chairs and clinical fit-out are funded as a practice is refitted, equipment is refinanced to release capital for an acquisition and imaging or diagnostic equipment is funded to add a chargeable service. What these situations share is a mismatch between the timing of a cost and the timing of the funds that will meet it; the facility exists to bridge that mismatch at a known price rather than to fund an indefinite shortfall.

A second group of cases is structural rather than urgent: surgery chairs and clinical fit-out are funded as a practice is refitted and equipment is refinanced to release capital for an acquisition. Here the borrower is choosing how to hold an asset over time, and the analysis is closer to a capital-structure decision than a funding emergency. Term, covenant flexibility, and early-repayment terms matter more than speed.

The route is a poor fit where the repayment plan depends on an event outside the borrower's control, or where the requirement is better met by a practice loan where the requirement is broader than equipment. In those cases the honest answer is that healthcare finance — asset would refinance a problem instead of resolving it, and the deciding test is whether the agreement amortises to title transfer or a technology-refresh upgrade, with residual values dependent on remaining service life and calibration records still holds if the timetable slips by a quarter.

Pricing is built rather than quoted. The headline rate reflects a flat or annual percentage rate applied to the asset value, plus a documentation fee, and the effective cost only becomes visible once arrangement fees, valuation and legal costs, and any exit or early-repayment charge are added to the same calculation. Comparing two offers on rate alone routinely selects the more expensive facility.

Three variables move the price materially: where the request sits against funding of up to 100% of the equipment cost where a manufacturer maintenance contract is in place, with a deposit required on used or uncontracted clinical equipment, how affordability from fee income, with the equipment's contribution to registered capacity considered alongside the practice's trading cash flow is evidenced, and the time the lender is exposed before the agreement amortises to title transfer or a technology-refresh upgrade, with residual values dependent on remaining service life and calibration records. Reducing the advance is usually the most efficient lever, because it lowers loss-given-default for the lender and therefore the margin charged. Figures discussed at enquiry stage are indicative and subject to valuation and full underwriting.

Borrowers should also price the cost of delay. Healthcare equipment agreements are typically documented in one to three weeks, with installation and commissioning scheduled around clinical operating hours. Clinical equipment is only worth its residual value while it is supported and calibrated, so funders underwrite the maintenance contract as closely as the machine. Where a transaction has a fixed deadline, a slightly higher margin from a lender that can meet the date is frequently cheaper than a lower margin that misses it and forfeits a deposit or a negotiated purchase price.

Eligibility for healthcare finance — asset is assessed on the asset first and the applicant second. Lenders test affordability from fee income, with the equipment's contribution to registered capacity considered alongside the practice's trading cash flow, then satisfy themselves that the agreement amortises to title transfer or a technology-refresh upgrade, with residual values dependent on remaining service life and calibration records remains achievable under stressed assumptions. Trading history, sector, and the quality of the security all move the answer, and a marginal case is far more often declined on evidence gaps than on the underlying numbers.

A complete submission normally contains confirmation of installation requirements and any building works, the supplier quotation with the maintenance and calibration contract, registration details for the practice and the responsible clinician and recent accounts and fee income by treatment type. Where any of these are missing, underwriters price the uncertainty rather than ignore it, so incomplete packs tend to return higher rates or lower advances rather than an outright refusal. Preparing the pack before approaching lenders is the single most effective way to protect the terms available.

Where the pack is thinner, underwriters ask for confirmation of installation requirements and any building works and the supplier quotation with the maintenance and calibration contract before they will commit, because those items evidence the part of the case the security cannot. Clinical equipment is only worth its residual value while it is supported and calibrated, so funders underwrite the maintenance contract as closely as the machine. The trade-off is cost: flexibility on criteria is almost always paid for in margin, fees, or a lower advance against value.

The principal risks in healthcare finance — asset are residual values falling where calibration and service records are incomplete, the agreement running beyond the point at which the equipment leaves manufacturer support and regulatory or clinical standards changing and making the equipment non-compliant. Clinical equipment is only worth its residual value while it is supported and calibrated, so funders underwrite the maintenance contract as closely as the machine. All of them are manageable when they are priced at the outset rather than discovered mid-transaction.

The most common failure mode is an exit that slips. The agreement amortises to title transfer or a technology-refresh upgrade, with residual values dependent on remaining service life and calibration records If that route depends on a sale or a refinance, a slower market extends the term, and extension terms are rarely as favourable as the original facility. Building contingency into the timetable is materially cheaper than negotiating it under pressure.

Independent valuation advice, early legal instruction, and a written repayment plan reviewed against a downside case address most of the exposure. Where borrowing is regulated, The Financial Conduct Authority conduct rules require suitability to be assessed and disclosed; where it is not, that discipline remains good practice rather than an obligation.

Late payment can cause you serious money problems. For help, go to moneyhelper.org.uk.